U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07434661) titled 'Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR' on Jan. 21.
Brief Summary: SAFE-HEART is a single-centre, randomized controlled trial comparing the safety and efficiency of Apixaban versus Warfarin in the early period (3 months) after repair or bioprosthetics of the mitral and aortic valve cardiac surgery in patients with atrial fibrillation requiring oral anticoagulation.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Valve Disease, Heart
Atrial Fibrillation (AF)
Valve Replacement Surgery
Aortic Valve Surgery
Mitral Valve Annuloplasty
Mitral Valve Repair
Mitral Valve Surgery
I...